Systematic review of ablative therapy for the treatment of renal allograft neoplasms

Table 1 Characteristics of studies meeting the criteria for the systematic review

Study	Design	Period	Total	Ablation	Ablation	Quality
			sample size	sample size	technique
			(P/N)	(P/N)
Charboneau et al[18]	R-CR	2002	1/1	1/1	RF	L
Shingleton et al[17]	R-CR	2002	1/1	1/1	CA	L
Baughman et al[19]	R-CR	2004	1/1	1/1	RF	L
Hruby et al[22]	R-CR	2006	1/1	1/1	CA	L
Goeman et al[21]	R-CR	2006	1/1	1/1	RF	L
Aron et al[23]	R-CR	2007	1/1	1/1	RF	L
Matevossian et al[24]	R-CR	2008	1/1	1/1	RF	L
Sanchez et al[26]	R-CR	2009	1/1	1/1	RF	L
Chakera A et al[27]	R-CR	2010	1/1	1/1	HIFU	L
Olivani et al[29]	R-CR	2011	1/1	1/1	RF	L
Silvestri et al[36]	R-CR	2014	1/1	1/1	CA	L
Christensen et al[38]	R-CR	2015	1/1	1/1	RF	L
Roy et al[20]	S-U-R-CS	2005	2/2	1/1	RF	L
Veltri et al[25]	S-U-R-CS	2009	3/3	3/3	RF	L
Elkentaoui et al[28]	S-U-R-CS	2010	39/42	2/2	RF	L
Leveridge et al[31]	S-U-R-CS	2011	47/53	3/3	RF	L
Ploussard et al[32]	S-U-R-CS	2012	12/17	2/2	CA	L
Swords et al[34]	S-U-R-CS	2013	4/4	1/1	RF	L
Vegso et al[35]	S-U-R-CS	2013	9/9	5/5	RF	L
Su et al[37]	S-U-R-CS	2014	4/5	1/2	RF	L
Hernàndez et al[39]	S-U-R-CS	2015	4/4	1/1	RF	L
Cool et al[41]	S-U-R-CS	2017	10/12	10/12	RF	A
Iezzi et al[42]	S-U-R-CS	2018	3/3	3/3	RF	L
Di Candio et al[43]	S-U-R-CS	2019	3/4	3/4	RF, HIFU	L
Gul et al[44]	S-U-R-CS	2019	6/6	6/6	CA, MW, IRE	L
Tillou et al[33]	M-U-R-CS	2012	79/79	5/5	RF	A
Cornelis et al[30]	M-U-R-CS	2011	20/24	20/24	RF, CA	A
Guleryuz et al[40]	M-C-R-CS	2016	92/92	14/14	RF, CA	H

P: Patient; N: Neoplasm; R: Retrospective; CR: Case report; RF: Radiofrequency ablation; L: Low; CA: Cryoablation; HIFU: High-intensity focused ultrasound; S: Single-centre; U: Uncontrolled; CS: Case series; A: Average; MW: Microwave ablation; IRE: Irreversible electroporation; M: Multi-centre; C: Controlled; H: High.